Prognostic significance of non-chest pain symptoms in patients with non-ST-segment elevation myocardial infarction
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Chest pain is an essential symptom in the diagnosis of acute coronary syndrome (ACS). One-third of patients with ACS present atypically, which can influence their receiving timely lifesaving therapy. Methods: A total of 617 NSTEMI patients from the Korea Acute MI Registry (KAMIR) and the Korea Working Group on MI (KorMI) databases were analyzed. The study population was divided into two groups by symptoms at presentation (typical symptoms group, 128; atypical symptoms groups, 128). Results: In this study population, 23% of patients presented without chest pain. After propensity score matching, the contact-to-device time (2,618 ± 381 minutes vs. 1,739 ± 241 minutes, p = 0.050), the symptoms-to-balloon time (3,426 ± 389 minutes vs. 2,366 ± 255 minutes, p = 0.024), and the door-to-balloon time (2,339 ± 380 minutes vs. 1,544 ± 244 minutes, p = 0.002) were significantly higher in the patients with atypical symptoms than in those with typical symptoms, respectively. Atypical symptoms were an independent predictor for 1-year mortality (hazard ratio, 2.820; 95% confidence interval, 1.058 to 7.515; p = 0.038). The Kaplan-Meier estimates showed higher risk for 12-month mortality in patients with atypical symptoms (p = 0.048) and no significant difference for 12-month major adverse cardiac events (p = 0.487). Conclusions: Acute myocardial infarction patients with atypical symptoms were not rare in clinical practice and showed a high risk of delayed reperfusion therapy. After imbalance between the groups was minimized by use of propensity score matching, patients who presented atypically had a high mortality rate.
Abstract
Background/Aims: Chest pain is an essential symptom in the diagnosis of acute coronary syndrome (ACS). One-third of patients with ACS present atypically, which can influence their receiving timely lifesaving therapy. Methods: A total of 617 NSTEMI patients from the Korea Acute MI Registry (KAMIR) and the Korea Working Group on MI (KorMI) databases were analyzed. The study population was divided into two groups by symptoms at presentation (typical symptoms group, 128; atypical symptoms groups, 128). Results: In this study population, 23% of patients presented without chest pain. After propensity score matching, the contact-to-device time (2,618 ± 381 minutes vs. 1,739 ± 241 minutes, p = 0.050), the symptoms-to-balloon time (3,426 ± 389 minutes vs. 2,366 ± 255 minutes, p = 0.024), and the door-to-balloon time (2,339 ± 380 minutes vs. 1,544 ± 244 minutes, p = 0.002) were significantly higher in the patients with atypical symptoms than in those with typical symptoms, respectively. Atypical symptoms were an independent predictor for 1-year mortality (hazard ratio, 2.820; 95% confidence interval, 1.058 to 7.515; p = 0.038). The Kaplan-Meier estimates showed higher risk for 12-month mortality in patients with atypical symptoms (p = 0.048) and no significant difference for 12-month major adverse cardiac events (p = 0.487). Conclusions: Acute myocardial infarction patients with atypical symptoms were not rare in clinical practice and showed a high risk of delayed reperfusion therapy. After imbalance between the groups was minimized by use of propensity score matching, patients who presented atypically had a high mortality rate.
참고문헌 (17)
- Canto JG, "Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain", JAMA, 283, pp.3223~3229 (2000)
- Roffi M, "2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)", Eur Heart J, 37, pp.267~315 (2016)
- Barron HV, "Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction 2", Cardiol Rev, 7, pp.156~160 (1999)
- Barron HV, "Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2", Circulation, 97, pp.1150~1156 (1998)
- Culic V, "Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors", Am Heart J, 144, pp.1012~1017 (2002)
- Kentsch M, "Angina intensity is not different in diabetic and non-diabetic patients with acute myocardial infarction", Z Kardiol, 92, pp.817~824 (2003)
- Chen W, "Gender differences in symptoms associated with acute myocardial infarction: a review of the research", Heart Lung, 34, pp.240~247 (2005)
- Wackers FJ, "Detection of silent myocardial ischemia in asymptomatic diabetic subjects:the DIAD study", Diabetes Care, 27, pp.1954~1961 (2004)
- Canto JG, "Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality", JAMA, 307, pp.813~822 (2012)
- DeVon HA, "Symptoms of acute coronary syndromes:are there gender differences? A review of the literature", Heart Lung, 31, pp.235~245 (2002)
- Mackay MH, "Gender differences in symptoms of myocardial ischaemia", Eur Heart J, 32, pp.3107~3114 (2011)
- Falcone C, "Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease", Int J Cardiol, 90, pp.219~227 (2003)
- Coronado BE, "Clinical features, triage, and outcome of patients presenting to the ED with suspected acute coronary syndromes but without pain: a multicenter study", Am J Emerg Med, 22, pp.568~574 (2004)
- Richman PB, "Clinical characteristics of diabetic vs nondiabetic patients who “rule-in” for acute myocardial infarction", Acad Emerg Med, 6, pp.719~723 (1999)
- Meshack AF, "Comparison of reported symptoms of acute myocardial infarction in Mexican Americans versus non-Hispanic whites (the Corpus Christi Heart Project)", Am J Cardiol, 82, pp.1329~1332 (1998)
- Katritsis DG, "Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes", Eur Heart J, 32, pp.32~40 (2011)
- Navarese EP, "Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis", Ann Intern Med, 158, pp.261~270 (2013)